Aptevo Therapeutics Inc. (APVO)
4.61
0.06 (1.32%)
At close: Jan 15, 2025, 3:59 PM
4.77
3.47%
After-hours Jan 15, 2025, 04:50 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -17.41M | 8.03M | -28.46M | -17.75M | -40.45M | -53.69M | 6.97M | -112.42M | -59.32M | -51.12M | -53.34M |
| Depreciation & Amortization | 567.00K | 901.00K | 1.14M | 1.41M | 2.23M | 2.39M | 3.13M | 3.36M | 2.91M | 2.02M | 666.00K |
| Stock-Based Compensation | 2.19M | 1.80M | 1.64M | 1.25M | 1.60M | 2.14M | 4.88M | 3.81M | 1.11M | 1.07M | 955.00K |
| Other Working Capital | -107.00K | 2.54M | -740.00K | 1.72M | 6.66M | -694.00K | -2.29M | -4.30M | 4.69M | 952.00K | 229.00K |
| Other Non-Cash Items | 10.00K | -33.90M | 6.64M | 411.00K | 673.00K | 988.00K | -52.06M | -16.66M | 3.69M | 304.00K | -18.00K |
| Deferred Income Tax | n/a | n/a | 4.00K | -12.23M | -4.25M | n/a | -2.00K | 71.21M | -1.36M | 117.00K | n/a |
| Change in Working Capital | 2.91M | 2.14M | -2.65M | -2.41M | -2.19M | -3.25M | -4.50M | 13.83M | 4.21M | 592.00K | 342.00K |
| Operating Cash Flow | -11.73M | -21.02M | -21.68M | -29.32M | -42.38M | -51.42M | -41.57M | -36.86M | -48.76M | -47.01M | -51.39M |
| Capital Expenditures | n/a | -29.00K | -713.00K | -88.00K | -153.00K | -976.00K | -1.40M | -2.51M | -1.53M | -989.00K | -1.02M |
| Acquisitions | n/a | n/a | n/a | 28.12M | 4.25M | 65.00K | 59.76M | n/a | n/a | -47.81M | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -16.54M | -99.63M | -44.88M | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 90.24M | 70.73M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | n/a | n/a | 28.12M | 4.25M | 73.77M | 30.86M | -44.88M | n/a | n/a | n/a |
| Investing Cash Flow | n/a | -29.00K | -713.00K | 28.03M | 4.10M | 72.80M | 29.46M | -47.39M | -1.53M | -48.80M | -1.02M |
| Debt Repayment | -3.47M | -12.27M | -10.55M | 2.63M | -137.00K | n/a | n/a | 18.04M | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -11.00K | n/a | n/a | -758.00K | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 3.04M | 2.72M | 26.48M | 21.25M | -58.00K | -1.41M | 19.53M | 71.24M | 51.33M | 99.40M | 52.41M |
| Financial Cash Flow | 6.00M | -2.62M | 26.16M | 23.87M | 20.15M | -787.00K | 9.53M | 89.30M | 51.33M | 99.40M | 52.41M |
| Net Cash Flow | -5.73M | -23.67M | 3.77M | 22.59M | -18.14M | 20.59M | -2.58M | 5.04M | 1.04M | 3.59M | n/a |
| Free Cash Flow | -11.73M | -21.05M | -22.39M | -29.41M | -42.54M | -52.40M | -42.98M | -39.37M | -50.29M | -48.00M | -52.41M |